A detailed history of Wells Fargo & Company transactions in Insmed Inc stock. As of the latest transaction made, Wells Fargo & Company holds 71,453 shares of INSM stock, worth $5.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,453
Previous 96,347 25.84%
Holding current value
$5.02 Million
Previous $2.99 Million 35.08%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$25.72 - $29.94 $640,273 - $745,326
-24,894 Reduced 25.84%
71,453 $1.94 Million
Q4 2023

Feb 09, 2024

SELL
$23.42 - $31.74 $403,971 - $547,483
-17,249 Reduced 15.18%
96,347 $2.99 Million
Q3 2023

Nov 13, 2023

SELL
$19.86 - $26.93 $598,103 - $811,023
-30,116 Reduced 20.96%
113,596 $2.87 Million
Q2 2023

Aug 15, 2023

BUY
$16.44 - $21.1 $444,800 - $570,881
27,056 Added 23.19%
143,712 $3.03 Million
Q1 2023

May 12, 2023

BUY
$16.26 - $21.73 $1.55 Million - $2.08 Million
95,574 Added 453.34%
116,656 $1.99 Million
Q4 2022

Feb 13, 2023

SELL
$16.98 - $23.15 $81,962 - $111,745
-4,827 Reduced 18.63%
21,082 $421,000
Q3 2022

Nov 14, 2022

SELL
$20.88 - $28.21 $11,776 - $15,910
-564 Reduced 2.13%
25,909 $558,000
Q2 2022

Aug 12, 2022

SELL
$17.07 - $25.71 $912,135 - $1.37 Million
-53,435 Reduced 66.87%
26,473 $521,000
Q1 2022

May 16, 2022

SELL
$20.42 - $28.13 $800,954 - $1.1 Million
-39,224 Reduced 32.92%
79,908 $1.88 Million
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $903,638 - $1.17 Million
-34,903 Reduced 22.66%
119,132 $3.25 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $1.77 Million - $2.32 Million
-78,729 Reduced 33.82%
154,035 $4.24 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $164,186 - $244,615
6,793 Added 3.01%
232,764 $6.63 Million
Q1 2021

May 13, 2021

SELL
$32.28 - $44.3 $839,699 - $1.15 Million
-26,013 Reduced 10.32%
225,971 $7.7 Million
Q4 2020

Feb 09, 2021

BUY
$31.45 - $40.54 $3.28 Million - $4.23 Million
104,232 Added 70.55%
251,984 $8.39 Million
Q3 2020

Nov 05, 2020

BUY
$26.0 - $34.5 $940,004 - $1.25 Million
36,154 Added 32.4%
147,752 $4.75 Million
Q2 2020

Aug 13, 2020

BUY
$14.11 - $29.42 $540,384 - $1.13 Million
38,298 Added 52.25%
111,598 $3.07 Million
Q1 2020

May 14, 2020

BUY
$13.63 - $33.98 $999,079 - $2.49 Million
73,300 New
73,300 $1.18 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.52B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.